Sugammadex Administration in Pregnancy

In this study, the investigators aimed to evaluate the maternal and fetal effect of sugammadex in pregnant patients undergoing a non-obstetric surgery. The investigators mainly focused on the short- and long-term adverse effects such as an abortion or a teratogenic effect and that may occur in fetus and the adverse effects that may be seen in mother.

Inclusion Criteria:Pregnant women who were operated under general anesthesia during pregnancy and who used sugammadex during the awakening phase.Exclusion Criteria:Patients with severe hepatic and renal impairmentPatients with missing dataPatients with fetal anomaly detected before the procedure